Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme

O. Majek, J. Danes, M. Skovajsova, H. Bartonkova, L. Buresova, D. Klimes, P. Brabec, P. Kozeny, L. Dusek,

. 2011 ; 11 () : 288. [pub] 20110510

Jazyk angličtina Země Anglie, Velká Británie

Typ dokumentu časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/bmc12028331

Grantová podpora
NS10650 MZ0 CEP - Centrální evidence projektů

BACKGROUND: The Czech Breast Cancer Screening Programme (CBCSP) was initiated in September 2002 by establishing a network of accredited centres. The aim of this article is to describe progress in the programme quality over time after the inception of the organised programme. METHODS: The CBCSP is monitored using an information system consisting of three principal components: 1) the national cancer registry, 2) a screening registry collecting data on all screening examinations, further assessments and final diagnoses at accredited programme centres, and 3) administrative databases of healthcare payers. Key performance indicators from the European Guidelines have been adopted for continuous monitoring. RESULTS: Breast cancer incidence in the Czech Republic has steadily been increasing, however with a growing proportion of less advanced stages. The mortality rate has recently stabilised. The screening registry includes 2,083,285 records on screening episodes between 2002 and 2008. In 2007-2008, 51% of eligible women aged 45-69 were screened. In 2008, the detection rates were 6.1 and 3.7 per 1,000 women in initial and subsequent screening respectively. Corresponding recall rates are 3.9% and 2.2%, however, it is necessary to pay attention to further assessment performed during the screening visits. Benign to malignant open biopsy ratio was 0.1. Of invasive cases detected in screening, 35.6% was less than 10 mm in diameter. Values of early performance indicators, as measured by both crude and standardized estimates, are generally improving and fulfil desirable targets set by European Guidelines. CONCLUSIONS: Mammography screening in the Czech Republic underwent successful transformation from opportunistic prevention to an organised programme. Values of early indicators confirm continuous improvement in different aspects of process quality. Further stimulation of participation through invitation system is necessary to exploit the full potential of screening mammography at the population level.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc12028331
003      
CZ-PrNML
005      
20141006172657.0
007      
ta
008      
120817e20110510enk f 000 0#eng||
009      
AR
024    7_
$a 10.1186/1471-2458-11-288 $2 doi
035    __
$a (PubMed)21554747
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a enk
100    1_
$a Májek, Ondřej $7 xx0156444 $u Institute of Biostatistics and Analyses, Masaryk University, Kamenice 126/3, 625 00 Brno, Czech Republic.
245    10
$a Breast cancer screening in the Czech Republic: time trends in performance indicators during the first seven years of the organised programme / $c O. Majek, J. Danes, M. Skovajsova, H. Bartonkova, L. Buresova, D. Klimes, P. Brabec, P. Kozeny, L. Dusek,
520    9_
$a BACKGROUND: The Czech Breast Cancer Screening Programme (CBCSP) was initiated in September 2002 by establishing a network of accredited centres. The aim of this article is to describe progress in the programme quality over time after the inception of the organised programme. METHODS: The CBCSP is monitored using an information system consisting of three principal components: 1) the national cancer registry, 2) a screening registry collecting data on all screening examinations, further assessments and final diagnoses at accredited programme centres, and 3) administrative databases of healthcare payers. Key performance indicators from the European Guidelines have been adopted for continuous monitoring. RESULTS: Breast cancer incidence in the Czech Republic has steadily been increasing, however with a growing proportion of less advanced stages. The mortality rate has recently stabilised. The screening registry includes 2,083,285 records on screening episodes between 2002 and 2008. In 2007-2008, 51% of eligible women aged 45-69 were screened. In 2008, the detection rates were 6.1 and 3.7 per 1,000 women in initial and subsequent screening respectively. Corresponding recall rates are 3.9% and 2.2%, however, it is necessary to pay attention to further assessment performed during the screening visits. Benign to malignant open biopsy ratio was 0.1. Of invasive cases detected in screening, 35.6% was less than 10 mm in diameter. Values of early performance indicators, as measured by both crude and standardized estimates, are generally improving and fulfil desirable targets set by European Guidelines. CONCLUSIONS: Mammography screening in the Czech Republic underwent successful transformation from opportunistic prevention to an organised programme. Values of early indicators confirm continuous improvement in different aspects of process quality. Further stimulation of participation through invitation system is necessary to exploit the full potential of screening mammography at the population level.
650    _2
$a senioři $7 D000368
650    _2
$a nádory prsu $x diagnóza $7 D001943
650    _2
$a ženské pohlaví $7 D005260
650    _2
$a podpora zdraví $7 D006293
650    _2
$a lidé $7 D006801
650    _2
$a mamografie $x využití $7 D008327
650    _2
$a plošný screening $x organizace a řízení $x využití $7 D008403
650    _2
$a lidé středního věku $7 D008875
650    _2
$a hodnocení programu $7 D015397
650    _2
$a ukazatele kvality zdravotní péče $7 D019984
650    _2
$a registrace $7 D012042
651    _2
$a Česká republika $7 D018153
655    _2
$a časopisecké články $7 D016428
655    _2
$a práce podpořená grantem $7 D013485
700    1_
$a Danes, Jan
700    1_
$a Skovajsová, Miroslava, $d 1957- $7 xx0010763
700    1_
$a Bartoňková, Helena $7 xx0053127
700    1#
$a Burešová, Lucie. $7 xx0120445
700    1#
$a Klimeš, Daniel. $7 mzk2007417337
700    1_
$a Brabec, Petr
700    1_
$a Kožený, Pavel
700    1_
$a Dušek, Ladislav, $d 1967- $7 mzk2003181727
773    0_
$w MED00008205 $t BMC Public Health $x 1471-2458 $g Roč. 11(20110510), s. 288
856    41
$u https://pubmed.ncbi.nlm.nih.gov/21554747 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y m $z 0
990    __
$a 20120817 $b ABA008
991    __
$a 20141006173134 $b ABA008
999    __
$a ok $b bmc $g 950373 $s 785677
BAS    __
$a 3
BAS    __
$a PreBMC
BMC    __
$a 2011 $b 11 $d 288 $e 20110510 $i 1471-2458 $m BMC public health $n BMC Public Health $x MED00008205
GRA    __
$a NS10650 $p MZ0
LZP    __
$a Pubmed-20120817/11/04

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace

Nahrávání dat ...